Carrier detection of pyruvate carboxylase deficiency in fibroblasts and lymphocytes

13Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Pyruvate carboxylase (E.C. 6.4.1.1) activity was determined in the circulating peripheral lymphocytes and cultured skin fibroblasts from the family of a patient with hepatic, cerebral, renal cortical, leukocyte, and fibroblast pyruvate carboxylase deficiency (PCPortland deficiency). Lymphocyte activities were: mother, 33- 39%; father, 11-29%; brother, 82-103%; and sister, 38-48% of the lowest normal. Fibroblasts from the patient’s mother and father had 42 and 34%, respectively, of the activity of the lowest normal. These data demonstrate that the disease is inherited in an autosomal recessive manner and that lymphocytes and fibroblasts can be used to detect carriers. Neither pyruvate carboxylase nor mitochondrial PEPCK activity in lymphocytes was increased by a 21-hr fast. Speculation: The demonstration that carriers of pyruvate carboxylase deficiency can be detected with a venous blood sample may allow, with the use of extensive family studies, the assignment of this enzyme to a chromosomal linkage group.© 1979 International Pediatric Research Foundation, Inc.

Cite

CITATION STYLE

APA

Atkin, B. M. (1979). Carrier detection of pyruvate carboxylase deficiency in fibroblasts and lymphocytes. Pediatric Research, 13(10), 1101–1104. https://doi.org/10.1203/00006450-197910000-00003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free